Patent Assignment
Reel/Frame 019925/0173
Assignment of Assignor's Interest
Recorded: 2007-10-05
Pages: 75
Assignors
PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP
Executed: 2007-02-06
CADUCEUS PRIVATE INVESTMENTS, L.P.
Executed: 2007-02-06
GEIGY, JUERG F.
Executed: 2007-02-06
SECURITY PACIFIC FINANCE, LTD.
Executed: 2007-02-06
GILLIN, ARNE J.
Executed: 2007-02-06
BIOTECHNOLOGY DEVELOPMENT FUND II, LP
Executed: 2007-02-06
MAC & CO.
Executed: 2007-02-06
BURRILL AGBIO CAPITAL FUND, L.P.
Executed: 2007-02-06
BURRILL BIOTECHNOLOGY CAPITAL, L.P.
Executed: 2007-02-06
BIOTECHNOLOGY DEVELOPMENT FUND, LP
Executed: 2007-02-06
URVATER, RONALD M.
Executed: 2007-02-06
BOHR, JAKOB
Executed: 2007-02-06
DANSK KAPITALANTAEG AKTIESELSKAG
Executed: 2007-02-06
PERNET, ERNEST
Executed: 2007-02-06
INGLEWOOD VENTURES L.P.
Executed: 2007-02-06
Assignee
METABASIS THERAPEUTICS, INC.
11119 NORTH TORREY PINES ROAD, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
2-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine Phosphatases
Application:
11/814,239 →
Publication:
US 2008/0070867
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.